• 54,029+ CME Conference Registrations Sold
  • 162,088+ Medical Conferences
  • 285 Specialties
  • 11,622 Organizers
  • 158,747 Speakers
  • 159 Countries
  • 4,828 Cities
Duration: CME/CE Points: Author(s):
CME : 0.75

Neurology : Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome is organized by American Academy of Neurology (AAN) and will be held during Aug 29, 2017 - Aug 29, 2020.

Conference Objectives are :

Upon completion of the article by Hennes et al, the participant should be able to:
• Identify clinical features in this study seen in conjunction with high anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a cohort of children with acquired demyelinating syndromes
• Describe the prognostic role for anti-MOG antibodies in identifying children after an initial demyelinating event who are at high risk of subsequent development of multiple sclerosis (MS) in this study
• Discuss the sensitivity and specificity of anti-MOG antibodies in the diagnosis of non-MS disease courses following an initial demyelinating event observed in this study

Additional details will be posted as soon as they are available.

Intended Audience



Activity Fee : Fee Details will be updated soon


Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.